CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 96 filers reported holding CARDIFF ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,079,000 | -42.3% | 463,000 | -19.6% | 0.51% | -34.7% |
| Q1 2021 | $5,334,000 | -82.2% | 576,000 | -65.4% | 0.78% | -80.0% |
| Q4 2020 | $29,908,000 | +21.7% | 1,662,500 | -4.0% | 3.91% | -18.7% |
| Q3 2020 | $24,571,000 | +731.2% | 1,731,600 | +193.5% | 4.80% | +704.9% |
| Q2 2020 | $2,956,000 | – | 590,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $16,797,000 | 13.61% |
| Octagon Capital Advisors LP | 982,753 | $6,545,000 | 1.61% |
| Altium Capital Management LP | 348,888 | $2,324,000 | 0.61% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $683,000 | 0.35% |
| Eventide Asset Management | 1,670,399 | $11,125,000 | 0.15% |
| Artal Group S.A. | 750,000 | $4,995,000 | 0.11% |
| Virtus ETF Advisers LLC | 25,770 | $172,000 | 0.08% |
| HighVista Strategies LLC | 15,501 | $103,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 13,500 | $90,000 | 0.05% |
| SCHOLTZ & COMPANY, LLC | 16,625 | $111,000 | 0.04% |